Table 1 Information on the compounds selected from the MMV Pandemic Response Box collectiona.

From: Screening of the Pandemic Response Box library identified promising compound candidate drug combinations against extensively drug-resistant Acinetobacter baumannii

MMV-ID (Trivial name)

Structureb

Original reported activity

Growth inhibition at 10 μM (%) (mean ± SD)

(n = 3)

A. baumannii

QS17-1084

5075

MMV396785 (Alexidine)

View full size image

Antifungal

100 ± 0.0

100 ± 0.0

MMV1578568 (Gepotidacin)

View full size image

Antibacterial

80.5 ± 1.5

95.3 ± 3.5

MMV1580854

View full size image

Antibacterial

96.8 ± 2.5

97.7 ± 1.9

MMV1578574 (Eravacycline)

View full size image

Antibacterial

99.5 ± 0.4

100 ± 0.0

MMV1578566 (Epetraborole)

View full size image

Antibacterial

93.8 ± 4.2

100 ± 0.0

MMV1634402 (Brilacidin)

View full size image

Antibacterial

99.5 ± 0.4

100 ± 0.0

MMV1578564 (MUT056399)

View full size image

Antibacterial

86.8 ± 2.9

95.4 ± 3.4

  1. aMMV, Medicine for Malaria Venture.
  2. bStructures were redrawn using ChemDraw Professional.